Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability
Haitao Luo,1 Bingbing Jiang,2 Bingyun Li,2–4 Zhaoliang Li,1 Bing-Hua Jiang,5 Yi Charlie Chen11Department of Biology, Natural Science Division, Alderson-Broaddus College, Philippi, 2Department of Orthopaedics, School of Medicine, West Virginia University, 3WVNano Initiative, 4Mary Babb...
Guardado en:
Autores principales: | Luo H, Jiang B, Li B, Li Z, Jiang BH, Chen YC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/65563d9ebaad47daa50103bb3a4581ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature
por: Felice Crocetto, et al.
Publicado: (2021) -
Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene
por: Luo L, et al.
Publicado: (2016) -
Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin T34A Gene [Corrigendum]
por: Luo L, et al.
Publicado: (2020) -
Kaempferol conjugated gold nanoclusters enabled efficient for anticancer therapeutics to A549 lung cancer cells
por: Govindaraju S, et al.
Publicado: (2019) -
Kaempferol Has Potent Protective and Antifibrillogenic Effects for α-Synuclein Neurotoxicity In Vitro
por: Masatoshi Inden, et al.
Publicado: (2021)